{
  "docId": "019de516-de84-709f-9864-0c2e708269aa",
  "docSlug": "d2a0e3b4a50bc196c7afb3f2c93e5906",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 38 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 38,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "dense",
  "nDataPoints": 60,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-de84-709f-9864-0c2e708269aa/25",
  "deckHref": "/decks/019de516-de84-709f-9864-0c2e708269aa",
  "deckJsonHref": "/decks/019de516-de84-709f-9864-0c2e708269aa.json",
  "deckAnchorHref": "/decks/019de516-de84-709f-9864-0c2e708269aa#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.035,
        "w": 0.756,
        "x": 0.17,
        "y": 0.945
      },
      "kind": "source-note",
      "text": "1. As of the first quarter of 2023, certain products were recategorized across the consumables, implantables and equipment product categories. This change was made as management believes this better aligns these products in their respective categories. Prior period presentations of product categories have been conformed to current product category structure to allow investors to evaluate results between periods on a consistent basis.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f6506a1-acd8-4570-8ab4-eea7b37a6674",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.701,
        "w": 0.909,
        "x": 0.047,
        "y": 0.17
      },
      "kind": "table",
      "text": "Rank Product/Franchises 3Q23 2Q23 1Q23 FY22 4Q22 3Q22 1 Ocuvite® + PreserVision® $104M $104M $81M $387M $114M $98M 2 Surgical Consumables¹ $93M $102M $95M $359M $94M $85M 3 SofLens® $60M $59M $60M $246M $62M $62M 4 Biotrue® ONEday $51M $49M $52M $201M $50M $53M 5 Bausch + Lomb Ultra® $51M $42M $51M $177M $43M $46M 6 Surgical Equipment¹ $47M $46M $44M $171M $45M $42M 7 Surgical Implantables¹ $45M $47M $44M $188M $49M $45M 8 Lumify® Franchise $44M $43M $38M $131M $35M $30M 9 renu® $43M $43M $42M $176M $47M $44M 10 Biotrue® Solutions Franchise $42M $49M $35M $153M $37M $39M",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4998f12-1c46-4fb9-8cb1-0e2b2797ed90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.59,
        "x": 0.047,
        "y": 0.069
      },
      "kind": "title",
      "text": "Top 10 Revenues (Includes FX Impact)",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73430eda-79e0-43ed-afff-d56cde082acd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}